OK
Cancel
close

You must be signed in to use this feature.

SIGN IN or REGISTER

Chabner Colloquium & 2016 STO Annual Meeting

November 11–12, 2016
The Liberty Hotel, Boston, MA. (map)
Program Brochure (PDF)
Abstract Book (PDF)

Session 1:
New Insights Into Cancer Drug Resistance

54.39

Epigenetic Mechanisms of Tumor Initiation and Evolution Bradley E. Bernstein, MD, PhD
Video

44.49

Developing Therapies for Transcriptionally Addicted Tumors Nathanael Gray, PhD
Video

Session 2: Targets That Defy Effective Therapy

33:36

Optimal MAPK Inhibition as a Key Component of Therapeutic Strategies for KRAS Mutant Cancers Ryan B. Corcoran, MD, PhD
Video

Session 3: Hematologic Malignancies

39:49

FLT3 Inhibitors in the Therapy of Acute Myeloid Leukemia Richard M. Stone, MD
Video

32:50

Dihydroorotate Dehydrogenase: An Unexpected Metabolic Vulnerability in Acute Myeloid Leukemia David B. Sykes, MD, PhD
Video

Session 4: Fellows Forum

26:01

Genomics of a Mitochondria-Rich Tumor Raj Gopal, MD, PhD
Video

25:36

Generation of Models of Human Hematologic Malignancies Using CRISPR Genome EngineeringZuzana Tothova, MD, PhD
Video

Session 6: Neo-antigens and the Immune Response

51:21

T-Cell Therapy: Current Applications and Future Directions Marcela V. Maus, MD, PhD
Video

46:58

Addressing Cancer Clonal Heterogeneity: Developing Personalized Neoantigen-Based Cancer VaccinesCatherine J. Wu, MD
Video

Session 7: Molecular Tumor Board

41:41

Molecular Tumor Board Moderator: Aditya Bardia, MD, MPH
Panelists: Darrell Borger, PhD; Leif W. Ellisen, MD, PhD; Justin F. Gainor, MD

Video

X
 

 

 

Brought to you in partnership with